Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21641868

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2011 Jul
First author
Gnant M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2011 Jul;12(7):610-1. doi: 10.1016/S1470-2045(11)70151-6.
    note
    Source null
    related pmid
    21708345
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2011 Oct;12(11):991-2. doi: 10.1016/S1470-2045(11)70252-2.
    note
    Source null
    related pmid
    21968221
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2011 Oct;12(11):991. doi: 10.1016/S1470-2045(11)70216-9.
    note
    Source null
    related pmid
    21968222
    relationship
    Comment in

Authors and identifiers

  1. name
    Gnant M
    type
    Author
  2. name
    Mlineritsch B
    type
    Author
  3. name
    Stoeger H
    type
    Author
  4. name
    Luschin-Ebengreuth G
    type
    Author
  5. name
    Heck D
    type
    Author
  6. name
    Menzel C
    type
    Author
  7. name
    Jakesz R
    type
    Author
  8. name
    Seifert M
    type
    Author
  9. name
    Hubalek M
    type
    Author
  10. name
    Pristauz G
    type
    Author
  11. name
    Bauernhofer T
    type
    Author
  12. name
    Eidtmann H
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gnant M
    type
    Author
  2. name
    Mlineritsch B
    type
    Author
  3. name
    Stoeger H
    type
    Author
  4. name
    Luschin-Ebengreuth G
    type
    Author
  5. name
    Heck D
    type
    Author
  6. name
    Menzel C
    type
    Author
  7. name
    Jakesz R
    type
    Author
  8. name
    Seifert M
    type
    Author
  9. name
    Hubalek M
    type
    Author
  10. name
    Pristauz G
    type
    Author
  11. name
    Bauernhofer T
    type
    Author
  12. name
    Eidtmann H
    type
    Author
bibliography ids
  1. nci-bib-57b94493067f5df58202db8d
book metadata
content sha256
e6aa83a06740b3bd0c746b8ddde1f75927e0363558d30abd2281a11e8e381fd4
document type
citation
dois
  1. 10.1016/S1470-2045(11)70122-X
electronic publication date
display
2011 Jun 5
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21641868
immutable id
pubmed:21641868@e6aa83a06740b3bd0c746b8ddde1f75927e0363558d30abd2281a11e8e381fd4
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
631-41
volume
12
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2011 Jul;12(7):610-1. doi: 10.1016/S1470-2045(11)70151-6.
    note
    Source null
    related pmid
    21708345
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2011 Oct;12(11):991-2. doi: 10.1016/S1470-2045(11)70252-2.
    note
    Source null
    related pmid
    21968221
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2011 Oct;12(11):991. doi: 10.1016/S1470-2045(11)70216-9.
    note
    Source null
    related pmid
    21968222
    relationship
    Comment in
outcomes validated
false
pmid
21641868
provenance
batch id
a366a1bc8ed89d8d7ca5
provider
NCBI PubMed ESummary
record sha256
8f53bfd5d7722cca2447700fdacb24827331fced9070c6a5c36450deff7722a1
response sha256
c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
retrieved at
2026-09-09T23:46:40.540025+00:00
publication date
display
2011 Jul
precision
month
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21641868/
title
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

Preserved source evidence · Not medical advice